These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26323558)

  • 1. MiR-873 acts as a novel sensitizer of glioma cells to cisplatin by targeting Bcl-2.
    Chen X; Zhang Y; Shi Y; Lian H; Tu H; Han S; Peng B; Liu W; He X
    Int J Oncol; 2015 Oct; 47(4):1603-11. PubMed ID: 26323558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-16 modulate temozolomide resistance by regulating BCL-2 in human glioma cells.
    Han J; Chen Q
    Int J Clin Exp Pathol; 2015; 8(10):12698-707. PubMed ID: 26722459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
    Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
    Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-136 targets E2F1 to reverse cisplatin chemosensitivity in glioma cells.
    Chen W; Yang Y; Chen B; Lu P; Zhan L; Yu Q; Cao K; Li Q
    J Neurooncol; 2014 Oct; 120(1):43-53. PubMed ID: 25139024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiRNA-451 plays a role as tumor suppressor in human glioma cells.
    Nan Y; Han L; Zhang A; Wang G; Jia Z; Yang Y; Yue X; Pu P; Zhong Y; Kang C
    Brain Res; 2010 Nov; 1359():14-21. PubMed ID: 20816946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-503 regulates the resistance of non-small cell lung cancer cells to cisplatin by targeting Bcl-2.
    Qiu T; Zhou L; Wang T; Xu J; Wang J; Chen W; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Int J Mol Med; 2013 Sep; 32(3):593-8. PubMed ID: 23856992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-16-1 plays a role in reducing migration and invasion of glioma cells.
    Li X; Ling N; Bai Y; Dong W; Hui GZ; Liu D; Zhao J; Hu J
    Anat Rec (Hoboken); 2013 Mar; 296(3):427-32. PubMed ID: 23175429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.
    Wang H; Zhang SY; Wang S; Lu J; Wu W; Weng L; Chen D; Zhang Y; Lu Z; Yang J; Chen Y; Zhang X; Chen X; Xi C; Lu D; Zhao S
    Neuro Oncol; 2009 Dec; 11(6):790-802. PubMed ID: 19289490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR‑501‑3p sensitizes glioma cells to cisplatin by targeting MYCN.
    Zhang CG; Yang F; Li YH; Sun Y; Liu XJ; Wu X
    Mol Med Rep; 2018 Nov; 18(5):4747-4752. PubMed ID: 30221699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is mda-7/IL-24 a potential target and biomarker for enhancing drug sensitivity in human glioma U87 cell line?
    Wang Q; Zhu Y; Yang P
    Anat Rec (Hoboken); 2013 Aug; 296(8):1154-60. PubMed ID: 23794295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TIMP3 regulates osteosarcoma cell migration, invasion, and chemotherapeutic resistances.
    Han XG; Li Y; Mo HM; Li K; Lin D; Zhao CQ; Zhao J; Tang TT
    Tumour Biol; 2016 Jul; 37(7):8857-67. PubMed ID: 26749283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin increases B-cell-lymphoma-2 expression via activation of protein kinase C and Akt2 in endometrial cancer cells.
    Rouette A; Parent S; Girouard J; Leblanc V; Asselin E
    Int J Cancer; 2012 Apr; 130(8):1755-67. PubMed ID: 21618512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
    Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
    Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
    Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
    Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Bax or Bcl-2 overexpression on the ceramide-dependent apoptotic pathway in glioma cells.
    Sawada M; Nakashima S; Banno Y; Yamakawa H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Nozawa Y
    Oncogene; 2000 Jul; 19(31):3508-20. PubMed ID: 10918609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
    Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines.
    Zhu W; Shan X; Wang T; Shu Y; Liu P
    Int J Cancer; 2010 Dec; 127(11):2520-9. PubMed ID: 20162574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑873 inhibits the progression of thyroid cancer by directly targeting ZEB1.
    Jiao D; Guo F; Fu Q
    Mol Med Rep; 2019 Aug; 20(2):1986-1993. PubMed ID: 31257462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.